Last reviewed · How we verify

NCT07267975

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

Completed Phase 3 Last updated 5 December 2025
What this trial tests

Phase 3 trial testing Ferrous sulphate in Iron Deficiency Anemia in 60 participants. Completed in 7 May 2025.

Timeline
7 January 2025
Primary endpoint
7 March 2025
7 May 2025

Quick facts

Lead sponsorUniversity of Child Health Sciences and Children's Hospital, Lahore
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date7 January 2025
Primary completion7 March 2025
Estimated completion7 May 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

University of Child Health Sciences and Children's Hospital, Lahore

Who can join

Adults 1 Day to 5, any sex, with Iron Deficiency Anemia or Iron Deficiency Anemia Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treating iron deficiency anemia in children with daily and alternate day oral iron therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ferrous sulphate

Trials testing the same drug.

Other recruiting trials for Iron Deficiency Anemia

Currently open trials in the same condition.

Other University of Child Health Sciences and Children's Hospital, Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07267975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing